Followers | 3368 |
Posts | 93161 |
Boards Moderated | 9 |
Alias Born | 10/05/2005 |

Saturday, August 19, 2023 5:57:26 PM
https://ir.neuraxis.com/news-events/presentations
Recent NRXS News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/03/2025 05:20:44 PM
- NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives • GlobeNewswire Inc. • 06/17/2025 12:00:00 PM
- NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS • GlobeNewswire Inc. • 06/10/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 08:30:40 PM
- NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 • GlobeNewswire Inc. • 05/27/2025 12:00:00 PM
- NeurAxis Announces Closing of $5.0 Million Registered Direct Offering • GlobeNewswire Inc. • 05/22/2025 05:03:01 PM
- NeurAxis Announces $5.0 Million Registered Direct Offering • GlobeNewswire Inc. • 05/21/2025 11:00:00 AM
- NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pediatric FAP/Functional Dyspepsia (FD) and Associated Nausea Symptoms • GlobeNewswire Inc. • 05/20/2025 12:00:00 PM
- NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues • GlobeNewswire Inc. • 05/12/2025 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 12:05:27 PM
- NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025 • GlobeNewswire Inc. • 05/05/2025 01:00:00 PM
- NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 • GlobeNewswire Inc. • 04/15/2025 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/14/2025 01:01:15 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/14/2025 01:00:27 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/04/2025 08:30:15 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/04/2025 08:15:34 PM
- NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues • GlobeNewswire Inc. • 03/20/2025 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2025 12:00:36 PM
- NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025 • GlobeNewswire Inc. • 03/12/2025 01:00:00 PM
- $PYPD - PolyPid Hits Major Milestone: Completes Trial Enrollment, Poised for Potential Breakthrough in $10 Billion Surgical Infection Market • InvestorsHub NewsWire • 03/11/2025 02:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/12/2025 01:21:26 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/05/2025 09:33:12 PM
- UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States • GlobeNewswire Inc. • 01/21/2025 06:45:22 PM
- NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States • GlobeNewswire Inc. • 01/21/2025 02:00:00 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM